Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Mitchel L. Zoler, PhD

    News

    Extravascular ICD surpasses goals in pivotal trial

    Author:
    Mitchel L. Zoler, PhD
    Publish date: September 15, 2022

    A novel “extravascular” ICD that avoids some limitations of prior ICD types surpassed its prespecified efficacy and safety goals in a pivotal...

    • Read More

    News

    MR and PET perform similarly for assessing CAD

    Author:
    Mitchel L. Zoler, PhD
    Publish date: September 1, 2022

    Head-to-head comparison of rubidium PET and cardiac MR showed comparable performance for identifying coronary obstructions.

    • Read More

    News

    Albuminuria linked to higher CVD risk in diabetes

    Author:
    Mitchel L. Zoler, PhD
    Publish date: August 28, 2022

    An analysis of more than 74,000 Danish people with type 2 diabetes showed an elevated CVD event rate in those with albuminuria.

    • Read More

    News

    Dapagliflozin’s HFpEF benefit recasts heart failure treatment: DELIVER

    Author:
    Mitchel L. Zoler, PhD
    Publish date: August 27, 2022

    Results from DELIVER made dapagliflozin the third SGLT2 inhibitor to benefit patients with HFpEF, cementing a new, ejection fraction–agnostic...

    • Read More

    Video

    DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics

    Author:
    Mitchel L. Zoler, PhD
    Publish date: November 17, 2019

    PHILADELPHIA – Further analyses from the DAPA-HF trial showed dapagliflozin cut death and heart failure events...

    • Read More

    Video

    Flu vaccine cuts infection severity in kids and adults

    Author:
    Mitchel L. Zoler, PhD
    Publish date: October 29, 2019

    Recent U.S. data compiled by the CDC documented that children and adults who received influenza vaccines had fewer severe infections.

    • Read More

    Video

    Oral beta-lactams provide noninferior postdischarge pyelonephritis treatment

    Author:
    Mitchel L. Zoler, PhD
    Publish date: October 5, 2019

    WASHINGTON – Beta-lactams were noninferior to fluoroquinolones or trimethoprim-...

    • Read More

    Video

    DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug

    Author:
    Mitchel L. Zoler, PhD
    Publish date: September 2, 2019

    PARIS – Proof that dapagliflozin significantly helped heart failure patients without diabetes recategorizes the...

    • Read More

    Video

    Overreliance on DAS scores undermines rheumatoid arthritis management

    Author:
    Mitchel L. Zoler, PhD
    Publish date: July 15, 2019

    MADRID – A rheumatoid arthritis patient says “DAS blindness” now pervades rheumatoid arthritis management and degrades care.

    • Read More

    Video

    Obeticholic acid reversed NASH liver fibrosis in phase 3 trial

    Author:
    Mitchel L. Zoler, PhD
    Publish date: April 12, 2019

    VIENNA – Phase 3 trial results showed obeticholic acid, already FDA approved, is the first drug to reverse liver fibrosis in NASH patients.

    • Read More

    Video

    New SLE classification criteria reset disease definition

    Author:
    Mitchel L. Zoler, PhD
    Publish date: June 22, 2018

    A weighted-point system lets new SLE criteria classify patients solely by immunology and nephritis or by new...

    • Read More

    Video

    VIDEO: Hepatitis C eradication cuts nonliver cancer rate

    Author:
    Mitchel L. Zoler, PhD
    Publish date: June 6, 2018

    WASHINGTON - U.S. data from thousands of treated hepatitis C patients implicates the virus as carcinogenic and a factor in a wide range of...

    • Read More

    Video

    VIDEO: Pelvic radiation surpasses brachytherapy/chemo for early endometrial cancer

    Author:
    Mitchel L. Zoler, PhD
    Publish date: March 27, 2018

    Pelvic radiation produced similar recurrence-free survival as vaginal brachytherapy plus chemo but with less toxicity and fewer local recurrences...

    • Read More

    Video

    VIDEO: Dabigatran effective for myocardial injury after noncardiac surgery

    Author:
    Mitchel L. Zoler, PhD
    Publish date: March 12, 2018

    ORLANDO – There’s now treatment for a condition that’s been rarely looked at until now.

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery